首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1897349

營養保健品和疫苗市場規模、佔有率和成長分析（按產品類型、應用、劑型、分銷管道和地區分類）－2026-2033年產業預測

Nutraceutical & Vaccine Market Size, Share, and Growth Analysis, By Product Type, By Application, By Formulation Type, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 202 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球營養保健品和疫苗市場規模將達到 613.8 億美元，到 2025 年將成長至 660.4 億美元，到 2033 年將成長至 1186.7 億美元，在預測期（2026-2033 年）內複合成長率為 7.6%。

全球營養保健品和疫苗市場正經歷強勁成長，這主要得益於消費者健康意識的不斷提高。營養保健品，包括機能性食品和膳食補充劑，因其潛在的健康益處和疾病預防作用而日益受到歡迎，從而帶動了需求的成長。同樣，由於對疾病預防的重視、技術的進步以及全球免疫接種工作的擴展，疫苗產業也蓬勃發展。各國政府和組織為確保疫苗的普及所做的努力進一步推動了市場成長。此外，聯合國兒童基金會和世界衛生組織等機構的策略正在為改善疫苗可及性鋪平道路。消費者越來越認知到營養在降低醫療保健成本方面的重要性，這推動了營養保健品市場的發展，使其成為健康管理和預防保健的重要組成部分。

全球營養保健品和疫苗市場成長要素

推動全球膳食補充劑和疫苗市場成長的關鍵因素是人們對預防性醫療保健日益成長的關注。隨著人們越來越意識到整體健康和疾病預防的重要性，對具有健康益處和增強免疫系統的產品需求激增。消費者正積極主動地關注自身健康，並且擴大尋求營養保健品和疫苗。這一趨勢受多種因素驅動，包括生活方式的改變、人口老化以及人們越來越希望透過優先考慮疾病預防而非僅依賴治療來降低醫療保健成本。

限制全球營養保健品和疫苗市場的因素

全球營養保健品和疫苗市場面臨的主要挑戰之一在於其複雜的法規結構和核准流程。營養保健品和疫苗的研發和上市需要進行廣泛的測試、臨床試驗，並遵守嚴格的監管標準，以確保其安全性、有效性和品質。這些繁瑣的程序耗時且耗力，對市場參與企業構成了障礙，尤其是資源有限的中小型企業。此外，嚴格的監管還會延緩產品上市，增加合規成本，阻礙營養保健品和疫苗產業的成長，並抑制創新。

全球營養保健品與疫苗市場趨勢

全球營養補充品和疫苗市場正呈現出向個人化醫療解決方案顯著發展的趨勢。這項轉變源自於消費者日益青睞根據自身健康狀況和遺傳傾向量身訂製的產品。基因組學、個人化醫療和先進數據分析領域的創新對於實現個人化營養和疫苗接種策略至關重要。為此，各公司正加速研發針對特定健康問題並提高療效的個人化營養保健品和疫苗。這一趨勢預示著精準醫療正在蓬勃發展，它強調識別和應對個別健康差異的重要性，以實現最佳治療效果。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

GlaxoSmithKline plc（GSK）（United Kingdom）
Pfizer Inc.（United States）
Sanofi Pasteur（France）
Merck & Co., Inc.（United States）
Moderna, Inc.（United States）
Novavax, Inc.（United States）
CSL Limited（Australia）
AstraZeneca plc（United Kingdom）
Johnson & Johnson（United States）
Bavarian Nordic A/S（Denmark）

結論與建議

簡介目錄

Product Code: SQMIG35I2337

Global Nutraceutical &Vaccine Market size was valued at USD 61.38 Billion in 2024 and is poised to grow from USD 66.04 Billion in 2025 to USD 118.67 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global nutraceutical and vaccine market is experiencing robust growth, fueled by heightened consumer awareness of health and wellness. Nutraceuticals, including functional foods and dietary supplements, are increasingly favored for their health benefits and disease prevention potential, leading to rising demand. Similarly, the vaccine sector is thriving, driven by a focus on disease control, advancements in technology, and expanded immunization initiatives globally. Commitment from governments and organizations to ensure universal access to vaccines has further enhanced growth. Additionally, strategies from entities like UNICEF and WHO are paving the way for improved vaccine accessibility. Consumers are recognizing the importance of nutrition in reducing healthcare costs, thus propelling the nutraceutical market as a vital component of health management and preventive care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutraceutical &Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutraceutical &Vaccine Market Segments Analysis

Global Nutraceutical & Vaccine Market is segmented by Product Type, Application, Formulation Type, Distribution Channel and region. Based on Product Type, the market is segmented into Vaccines and Dietary Supplements. Based on Application, the market is segmented into Sports Nutrition, General Well-Being, Immune & Digestive Health, Bone & Joint Health, Heart Health, Disease Prevention and Weight loss. Based on Formulation Type, the market is segmented into Tablets, Capsules, Powders and Liquids. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Sales and Super Markets. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nutraceutical &Vaccine Market

A key catalyst for growth in the global nutraceutical and vaccine market is the heightened focus on preventive healthcare. As individuals become more aware of the significance of promoting overall wellness and mitigating diseases, there is an escalating demand for products that provide health benefits and strengthen the immune system. Consumers increasingly pursue nutraceuticals and vaccines, reflecting a proactive approach toward their health. This trend is driven by various elements, including evolving lifestyles, an aging demographic, and a growing desire to lower healthcare expenses by prioritizing the prevention of illnesses instead of relying solely on treatments.

Restraints in the Global Nutraceutical &Vaccine Market

A significant challenge faced by the global nutraceutical and vaccine market lies in the complex regulatory frameworks and approval processes. The pathway for developing and bringing nutraceuticals and vaccines to market necessitates thorough testing, clinical trials, and compliance with rigorous regulatory standards to guarantee safety, efficacy, and quality. These demanding procedures can be both lengthy and expensive, creating obstacles for market participants, particularly for smaller firms with constrained resources. Additionally, stringent regulations may lead to delays in product introduction and escalate compliance costs, which can stifle growth and hinder innovation within the nutraceutical and vaccine industries.

Market Trends of the Global Nutraceutical &Vaccine Market

The global nutraceutical and vaccine market is witnessing a notable trend towards personalization and customization in healthcare solutions. This shift is driven by an increasing consumer preference for products that align with their unique health profiles and genetic predispositions. Innovations in genomics, personalized medicine, and advanced data analytics are pivotal in enabling tailored nutrition and vaccination strategies. As a response, companies are increasingly formulating personalized nutraceuticals and vaccines that address specific health issues and enhance efficacy. This trend signifies a broader movement towards precision healthcare, emphasizing the importance of recognizing and catering to individual health variations for optimal therapeutic results.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Nutraceutical & Vaccine Market Size by Product Type & CAGR (2026-2033)

Market Overview
Vaccines
Dietary Supplements

Global Nutraceutical & Vaccine Market Size by Application & CAGR (2026-2033)

Market Overview
Sports Nutrition
General Well-Being
Immune & Digestive Health
Bone & Joint Health
Heart Health
Disease Prevention
Weight loss

Global Nutraceutical & Vaccine Market Size by Formulation Type & CAGR (2026-2033)

Market Overview
Tablets
Capsules
Powders
Liquids

Global Nutraceutical & Vaccine Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Sales
Super Markets

Global Nutraceutical & Vaccine Market Size & CAGR (2026-2033)

North America (Product Type, Application, Formulation Type, Distribution Channel)
- US
- Canada
Europe (Product Type, Application, Formulation Type, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, Formulation Type, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, Formulation Type, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, Formulation Type, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GlaxoSmithKline plc (GSK) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi Pasteur (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novavax, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bavarian Nordic A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments